Kelly Michael
Procare Medical Associates LLC, Sports Medicine.
Cureus. 2017 May 15;9(5):e1251. doi: 10.7759/cureus.1251.
This technical report details the results of an uncontrolled study of EyeGuide Focus, a 10-second concussion management tool which relies on eye tracking to determine the potential impairment of visual attention, an indicator often of mild traumatic brain injury (mTBI). Essentially, people who can visually keep steady and accurate attention on a moving object in their environment likely suffer from no impairment. However, if after a potential mTBI event, subjects cannot keep attention on a moving object in a normal way as demonstrated on their previous healthy baseline tests. This may indicate possible neurological impairment. Now deployed at multiple locations across the United States, Focus (EyeGuide, Lubbock, Texas, United States) to date, has recorded more than 4,000 test scores. Our data analysis of these results shows the promise of Focus as a low-cost, ocular-based impairment test for assessing potential neurological impairment caused by mTBI in subjects ages eight and older.
本技术报告详细介绍了对EyeGuide Focus进行的一项非对照研究的结果。EyeGuide Focus是一种10秒的脑震荡管理工具,它依靠眼动追踪来确定视觉注意力的潜在损伤,而视觉注意力损伤通常是轻度创伤性脑损伤(mTBI)的一个指标。从本质上讲,能够在视觉上稳定而准确地关注周围环境中移动物体的人可能没有损伤。然而,如果在可能发生mTBI事件后,受试者无法像在之前健康基线测试中所显示的那样以正常方式关注移动物体,这可能表明存在潜在的神经损伤。目前,Focus(EyeGuide,美国得克萨斯州拉伯克)已在美国多个地点部署,迄今为止已记录了4000多个测试分数。我们对这些结果的数据分析表明,Focus有望成为一种低成本的、基于眼部的损伤测试,用于评估8岁及以上受试者因mTBI导致的潜在神经损伤。